Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
Incyte Corporation
Incyte Corporation